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Abstract
Charcot-Marie-Tooth (CMT) disease or hereditary motor and sensory neuropathy is the
most prevalent inherited peripheral neuropathy and is associated with over 90 causative
genes. Mutations in neurofilament light polypeptide gene, NEFL cause CMT2E, an axonal
form of CMT that results in abnormal structures and/or functions of peripheral axons in spi-
nal cord motor neurons and dorsal root ganglion neurons. We have previously generated
and characterized a knock-in mouse model of CMT2E with the N98S mutation in Nefl that
presented with multiple inclusions in spinal cord neurons. In this report, we conduct immuno-
fluorescence studies of cultured dorsal root ganglia (DRG) from NeflN98S/+ mice, and show
that inclusions found in DRG neurites can occur in embryonic stages. Ultrastructural analy-
ses reveal that the inclusions are disordered neurofilaments packed in high density, segre-
gated from other organelles. Immunochemical studies show decreased NFL protein levels
in DRG, cerebellum and spinal cord in NeflN98S/+ mice, and total NFL protein pool is shifted
toward the triton-insoluble fraction. Our findings reveal the nature of the inclusions in
NeflN98S/+ mice, provide useful information to understand mechanisms of CMT2E disease,
and identify DRG from NeflN98S/+ mice as a useful cell line model for therapeutic discoveries.
Introduction
Charcot-Marie- Tooth (CMT) diseases are the most common inherited sensory and motor
neuropathies with a reported prevalence of 1 in 2,500 people worldwide [1]. Nerves outside
the brain and spinal cord are damaged, causing muscle weakness and numbness in the legs
and arms. There have been over 90 genes identified to cause CMT. CMT is divided into two
major types, CMT1 and CMT2, based on nerve conduction velocities. CMT1 is primarily a
demyelinating neuropathy and has a reduced conduction velocity, whereas CMT2 is largely an
axonal neuropathy and has a fairly normal conduction velocity.
Neurofilament light polypeptide gene (NEFL) has been identified as the causative gene in
CMT2E [2]. The NEFL gene encodes neurofilament light polypeptide (NFL), one of the
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neuronal intermediate filaments proteins (IFs) that form the major structural framework that
maintains the diameter of the axon and thus the normal transmission of nerve signals. Neuro-
nal IFs consist of the neurofilament triplet proteins (NFL, NFM and NFH for neurofilament
light, middle and high), α-internexin and peripherin [3]. Like all intermediate filaments, each
monomer of NFL protein is composed of an α-helical rod domain flanked by N-terminal head
domain and C-terminal tail domain [3]. The α-helical rod domain is necessary for the forma-
tion of a coiled-coil dimer, which is the first step in intermediate filament assembly. Human
NFL can self-assemble in the absence of other intermediate filament proteins, but forms a
much more elaborate network when either NFM or NFH is present [4]. In vivo, NFL is always
present along with NFM throughout development, whereas NFH appears somewhat later [5].
Currently, over 18 mutations in the NEFL gene have been linked to CMT disease (Human
intermediate filament database: http://www.interfil.org/details.php?id=NM_006158).
Although these mutations are generally considered to cause CMT2E, there are cases of patients
with an NEFL mutation who present with a slower nerve conduction velocity resembling
CMT1F [6, 7]. Two autosomal recessive NEFL mutations have also been reported, causing
truncated NFL proteins resulting in a severe form of CMT [8, 9].
The N98S mutation is located at the beginning of the rod domain, and transfection experi-
ments have shown that the normal intermediate filament network is disrupted both in the
absence and presence of NFM [10]. The N98S mutation was first described in sporadic cases,
and was characterized by early-onset sensorimotor neuropathy with variable clinical features
including motor delay, mental retardation, hearing loss, nystagmus and cerebellar ataxia [8,
11–13]. Two recent familial cases have been reported with slowing NCV close to the demyelin-
ating or intermediate CMT, and delayed motor milestones with complex clinical features
including cerebellar ataxia [11].
We have established a knock-in NeflN98S/+ mouse model that recapitulates most of the fea-
tures of patients with this mutation [14]. The animals had a tremor and showed decrease in
balance. Immunohistochemical analyses showed multiple inclusions in the cell bodies and
axons of spinal cord neurons and dorsal root ganglia, disorganized processes in the cerebellum
and abnormal processes in the cerebral cortex and pons [2]. However, details of the nature of
these inclusions are lacking. Here we have conducted electron microscopy and immunocyto-
chemical studies on cultured dorsal root ganglia from adult mice in order to get a better under-
standing of the composition of these inclusions and try to unravel the mechanism of the
disease.
Results
Neurofilament accumulations in cultured dorsal root ganglia neurons
from adult NeflN98S/+ mice
We have previously observed the presence of neurofilamentous inclusions in the cell bodies
and processes of the dorsal root ganglia (DRG) of the NeflN98S/+ mice (14). We performed
immunocytochemical studies of cultured DRG neurons from 4-month-old mice with anti-
NFL antibody (Fig 1). Cultured DRG neurons from Nefl+/+ mice showed cell body staining
and continuous process labeling (Fig 1A). At a higher power, filamentous structures were
observed in the cell body (Fig 1B). In contrast, DRG neurons from NeflN98S/+ mice showed
strong cell body labeling and a punctate pattern of process labeling, where a number of
enlarged and abnormally intense punctae were labeled (pointed by arrows). The inset is a low
exposure image of the cell body pointed by the arrowhead. At higher magnification, neurofila-
ment accumulations could be seen in the cell body and the filamentous structure seen in
Nefl+/+ was disrupted in NeflN98S/+ DRG neurons (Fig 1D). In addition, the staining of the
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processes from the cultured NeflN98S/+ DRGs was very weak relative to the cell body staining
when compared to the processes and cell bodies of the cultured Nefl+/+ DRGs (Fig 1).
Abnormal neurofilament accumulations in cultured embryonic DRG
explants from NeflN98S/+ mice
We also compared the expression pattern of neurofilaments in embryonic DRG explants from
Nefl+/+ and NeflN98S/+ mice embryos at E15 in vitro (Fig 2). By using embryonic DRG explants,
the original architecture of the DRG is maintained with preserved interactions between DRG
neurons with non-neuronal cells; additionally, it provides useful information of NeflN98S/+
Fig 1. Immunofluorescence micrographs of cultured DRG neurons from Nefl+/+ and NeflN98S/+ mice labeling NFL. (A and C) Low power
views of DRG neurons from Nefl+/+ (A) and NeflN98S/+ (C) mice. Note that in NeflN98S/+ DRG neurons, the processes are characterized by large
amounts of enlarged and bright particles along the processes, pointed by arrows (C). (B and D) High-magnification images of DRG neurons as
seen in Fig A and C. Note the filamentous structure in Nefl+/+ DRG neuron (B). In contrast, disrupted neurofilament network and enlarged
neurofilament particles (pointed by arrows) along the processes can be seen in NeflN98S/+ DRG neurons (D). A low intensity image of DRG
neurons pointed by the arrowhead is shown in the inset (D) that also shows the broken neurofilamentous network. NeflN98S/+, n = 8; Nefl+/+,
n = 5. Scale bars = 50 μm (A and C) and 25 μm (B and D).
https://doi.org/10.1371/journal.pone.0180038.g001
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embryos during development. After 72 h in culture, Nefl+/+ DRG explants extended tightly fas-
ciculated bundles of axons, which showed a pattern of continuous labeling with anti-NFL anti-
body (Fig 2A and 2B). NeflN98S/+ DRG explants extended a network of axons that did not show
any obvious morphological abnormalities at low magnification (Fig 2A and 2C). However, at
higher magnification a punctate pattern was observed for NeflN98S/+ axons, where a lot of
brighter and enlarged punctae were observed (Fig 2D). This punctate pattern of NeflN98S/+
embryonic DRG explants is reminiscent of that in dissociated DRG neurons from NeflN98S/+
adult mice (Fig 1C and 1D), indicating that abnormal neurofilament organization in NeflN98S/+
DRGs may occur as early as E15 embryos.
Fig 2. Immunofluorescence micrographs of cultured DRG explants from wild-type and NeflN98S/+ mice embryos (E15) labeling NFL. (A
and C) Low power views of DRG explants from Nefl+/+ (A) and NeflN98S/+ (C) embryos cultured on the laminin-coated coverslip for 3 days. (B)
Higher magnification of the boxed area of wild-type DRG in Fig A. Note the processes are labeled quite uniformly with anti-NFL antibody. (D)
Higher magnification of the boxed area of NeflN98S/+ DRG in Fig C. Note the processes are characterized by a large amount of bright particles
along the processes. 3 Nefl+/+ females bred with NeflN98S/+ males were sacrificed, and embryos were collected and genotyped. DRG explants
from those embryos were cultured. Embryos for Nefl+/+, n = 10. Embryos for NeflN98S/+, n = 11. Scale bars = 500 μm (A and C) and 100 μm (B
and D).
https://doi.org/10.1371/journal.pone.0180038.g002
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Electron microscopy of DRG from adult mice
The NFL-positive inclusions were observed in cultured DRGs in vitro are similar to the immu-
nohistochemical staining of DRGs from adult NeflN98S/+ mice (14). To determine the nature of
these neurofilamentous inclusions, we performed an electron microscopic study of DRGs
from adult mice. In the low-power images of DRG cell soma (Fig 3A and 3C), there was an
apparent difference in the ultrastructural organization of the cell body region, where numer-
ous electron-lucent patches were observed throughout the soma of NeflN98S/+ DRG (Fig 3C).
Fig 3. Electron micrographs of DRG cell soma of wild-type and NeflN98S/+ mice. (A and C) Low power views of cell soma of
DRG from wild-type (A) and NeflN98S/+ (C) mice. Note the large amount of aggregates throughout the soma of NeflN98S/+ DRG (C).
(B and D) High power views of asterisk-labeled areas in Fig A and C. The filamentous structure formed by intermediate filaments is
pointed by the arrow in Nefl+/+ DRG (B). Massive accumulation of disordered neurofilaments is observed in NeflN98S/+ DRG (D).
The density of neurofilaments is very high and few other cytoplasmic elements can be seen within the aggregates. Scale
bars = 2 μm (A and C) and 500 nm (B and D).
https://doi.org/10.1371/journal.pone.0180038.g003
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Higher-power image of the asterisk-labeled region of Fig 3A showed that in Nefl+/+ DRGs, fila-
mentous structures formed by individual intermediate filaments can be seen in the soma
(pointed by arrow) (Fig 3B). In contrast, a high-power image of the asterisk-labeled electron-
lucent region in Fig 3C showed massive accumulations of disordered neurofilaments packed
together in high density. Few other cytoplasmic components were seen within the accumula-
tions in NeflN98S/+ DRG cell soma (Fig 3D). This EM result is consistent with the immunohis-
tochemical result of DRG from our previous studies, showing neurofilament aggregates in
NeflN98S/+ DRG cell body at the light microscopic level [14]. The results show that these aggre-
gates consist of bundles of neurofilaments, rather than amorphous aggregates.
The axons of the DRGs were also examined by EM (Fig 4). Both microtubules and neurofi-
laments were in the axons of Nefl+/+ DRGs, and neurofilaments were distributed among
microtubules and other organelles (Fig 4A and 4B). Distinct patterns of cytoskeletal organiza-
tion were observed from axons of NeflN98S/+ DRG (Fig 4C–4G). In one transverse section of an
axon, few neurofilaments were found; instead, microtubules were the predominant structures
in the axon of NeflN98S/+ DRG (Fig 4C and 4D). In another section of an axon under low
power, mitochondria and some other organelles were surrounded by some fiber-like structures
of high density (Fig 4E). A high power view of the asterisk-labeled area showed that mitochon-
dria and microtubules were found in that area with few neurofilaments (Fig 4F). In contrast,
in another area, we observed what appeared to be bundles of intermediate filaments (Fig 4E)
surrounded by microtubules and other organelles. A high power view of the area pointed by a
diamond confirmed the presence of neurofilaments that formed the massive accumulations
(Fig 4G).
Electron microscopy of cultured DRG neurons from adult mice
To get a better understanding of the punctate pattern of the NeflN98S/+ DRG cultures observed
in Fig 1, electron microscopy was performed on cultured DRG neurons (Fig 5). A lower mag-
nification image of Nefl+/+ DRGs showed that electron-lucent bundles form a network-like
structure throughout the cell body region (Fig 5A). A higher magnification image of the aster-
isk-labeled area revealed that the electron-lucent bundles consisted of filamentous structures,
which were believed to be neurofilaments (Fig 5B). In NeflN98S/+ DRG neurons, however, the
electron-lucent bundles disappeared. Instead, a large electron-lucent mass accumulated in the
center of the cell body, and was segregated from the electron-dense cytosolic components in
the NeflN98S/+ DRG neuron (Fig 5D). A higher power image of the asterisk-labeled area showed
that the large electron-lucent mass was composed almost exclusively of disorganized neurofila-
ments, in the absence of other cellular components (Fig 5E). Longitudinal sections of processes
from Nefl+/+ and NeflN98S/+ DRG neurons were also examined using electron microscopy. Neu-
rofilaments (filamentous structures with a smaller diameter) and microtubules (larger diame-
ter) ran in parallel bundles in the processes of Nefl+/+ DRGs (Fig 5C). However, in one image
of the NeflN98S/+ DRGs, the process was swollen and was filled with large numbers of neurofila-
ments (Fig 5F). The massive accumulations of neurofilaments found in enlarged processes of
NeflN98S/+ DRGs would almost certainly be strongly stained by NFL antibodies in immunofluo-
rescence. This result is consistent with the finding of many bright and enlarged punctae labeled
by anti-NFL antibody in Fig 1C.
Neurofilament proteins in NeflN98S/+ mice are reduced in both Triton-X
100 soluble and insoluble fractions
We have previously examined the total protein levels of NFL from brain, spinal cord and sci-
atic nerve of NeflN98S/+ mice, and found a decrease in NFL protein levels in all three tissues
Neurofilamentous inclusions in a CMT2E mouse model
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Fig 4. Electron micrographs of cross sections of DRG axons of wild-type and NeflN98S/+ mice. (A, C
and E) Low power views of DRG axons from Nefl+/+ (A) and NeflN98S/+ (C and E) mice. (B) A high power view
of the asterisk-labeled area in Nefl+/+ DRG axons from Fig A. Microtubules (pointed by an arrowhead) and
neurofilaments (pointed by an arrow) are interspersed. (D) A high power view of the asterisk-labeled area in
one cross section of NeflN98S/+ DRG axons from Fig C. Neurofilaments are barely seen and replaced by more
microtubules (pointed by an arrowhead). (F) A high power view of the asterisk-labeled area in another cross
section of NeflN98S/+ DRG axons from Fig E. Microtubules (pointed by an arrowhead) and barely any
neurofilaments can be seen in this area. (G) A high power view of the diamond-labeled area in another cross
section of NeflN98S/+ DRG axons from Fig E. Neurofilaments are packed at high density in this area, almost
Neurofilamentous inclusions in a CMT2E mouse model
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[14]. As N98S NFL proteins formed massive accumulations in DRGs, we assessed changes in
NFL solubility in the cerebellum, DRG and spinal cord using Triton-X 100 (Fig 6). We were
interested in determining whether the percentage of Triton-X100 soluble protein decreased in
the mutant animals, which might suggest that the aggregates are less soluble. We found that all
three tissues from NeflN98S/+ mice showed a reduction in Triton-X 100 soluble NFL proteins
(Fig 6A, 6D and 6G). Triton soluble NFL proteins in NeflN98S/+ DRGs had the greatest decrease
to 16% (84% decrease) of that of Nefl+/+ (Fig 6D), and exhibited a 58% decrease in cerebellum
(Fig 6A) and a 43% decrease in spinal cord (Fig 6G). In the Triton insoluble fractions,
NeflN98S/+ DRGs showed a 75% decrease in NFL protein compared to Nefl+/+ (Fig 6E), whereas
exclusive of any other organelles. (E, F and G) Microtubules and other organelles are segregated from the
neurofilament aggregates in this cross section of NeflN98S/+ DRG axons. Scale bars = 500 nm (A, C and E)
and 200 nm (B, D, F and G).
https://doi.org/10.1371/journal.pone.0180038.g004
Fig 5. Electron micrographs of cultured DRG neurons from wild-type and NeflN98S/+ mice. (A and B) EM of cell soma of wild-type. Fig B is
a higher magnification view of the asterisk-labeled area in Fig A. Filamentous structures formed by intermediate filaments can been seen
throughout the cell body, next to organelles such as mitochondria. (C) A longitudinal section of processes of Nefl+/+ DRG. Bundles of
microtubules and intermediate filaments are running in parallel alongside the processes. (D and E) EM of cell soma of NeflN98S/+ DRG. Fig E is a
higher magnification view of the asterisk-labeled area in Fig D. Massive accumulation of disordered neurofilaments is observed in the soma of
NeflN98S/+ DRG (D). The density of neurofilaments is very high and few other cytoplasmic elements can be seen within the accumulations (E).
(F) A longitudinal section of processes of NeflN98S/+ DRG. An enlarged process area of disorganized filamentous accumulation can be seen.
Scale bars = 2 μm (A and D) and 500 nm (B, C, E and F).
https://doi.org/10.1371/journal.pone.0180038.g005
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cerebellum and spinal cord of NeflN98S/+ exhibited a 33% and a 20% decrease compared to
Nefl+/+, respectively (Fig 6B and 6H).
The ratio of soluble- to insoluble-fraction of NFL proteins was calculated for each tissue by
dividing the normalized soluble NFL proteins to the insoluble NFL proteins. The ratio in all
the three tissues of NeflN98S/+ mice is significantly lower than that of Nefl+/+ (Fig 6C, 6F and
6I), suggesting that the insoluble NFL proteins account for a larger portion of the total NFL
protein pool in NeflN98S/+ mice.
Materials and methods
NeflN98S/+ mice
NeflN98S/+ mice were generated in our laboratory as described previously[14]. The animals are
maintained in a C57BL6 background obtained from Jackson Laboratory. The mice have been
deposited at Jackson Laboratory and are available for use upon request. Mice were maintained
Fig 6. NeflN98S/+ mice showing reduced protein levels of NFL in both triton-X 100 soluble and triton-X 100 insoluble fractions of
cerebellum, DRG and spinal cord. A, D and G) Quantitative data from western blots of triton soluble fraction of cerebellum, DRG and spinal
cord, respectively. The intensity of NFL was normalized to that of GAPDH. NFL levels in Nefl+/+ were further normalized to 100. (B, E and H)
Quantitative data from western blots of triton insoluble fraction of cerebellum, DRG and spinal cord, respectively. NFL levels in Nefl+/+ were
normalized to 100. (C, F and I) The ratio of triton soluble NFL to triton insoluble NFL in cerebellum, DRG and spinal cord, respectively. The
ratio of Nefl+/+ was normalized to 100. A litter of 4 Nefl+/+ and 4 NeflN98S/+ mice was used in this study. * p < 0.05.
https://doi.org/10.1371/journal.pone.0180038.g006
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in sterilized micro-isolator cages housed in virus-free barrier facilities, and fed with autoclaved
food and water. All animal studies were performed according to a protocol approved by the
Institutional Care and Use Committee (IACUC) at Columbia University Medical Center.
Primary neuronal cultures
For dissociated adult dorsal root ganglia neurons, mice of 3–6 months were euthanized by
CO2 exposure followed by cervical dislocation. DRGs were collected from the spinal column
and transferred to ice-cold HBSS. Roots and nonneuronal tissue were trimmed from DRGs
with fine forceps and a micro knife. Trimmed DRGs were incubated with 1.25 mg/ml collage-
nase for 90 min at 37˚C, 5% CO2, and incubated with 0.25% trypsin for 5 min at 37˚C. DRGs
were washed and resuspended in complete medium (see below), and were dissociated into sin-
gle cells by gentle trituration. A cushion of 2 ml 15% BSA was slowly added to the bottom of
the cell suspension to remove debris through a centrifugation step of 200 x g for 10 min. For
immunofluorescence, DRG neurons were plated on coverslips pre-coated with poly-D-lysine
(100 μg/ml, Sigma, P-0899) and laminin (5 μg /ml, Sigma, L-2020) for 2 h at 37˚C and 5% CO2
to allow adherence. Then wells were flooded with complete medium consisting of Ham’s F-12
medium, 10% horse serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg /ml streptomycin,
50 μM 5-fluoro-2’-deoxyuridine and 150 μM uridine. For electron microscopy, DRG neurons
were plated on 8-well Permanox chamber slides (Nunc).
For embryonic DRG explants, DRGs were dissected from individual embryonic day 15
(E15) Nefl+/+ and NeflN98S/+ littermates. DRG explants were placed on coverslips pre-coated
with poly-D-lysine and laminin, and grown in neurobasal medium supplemented with B27
(Invitrogen), 2 mM L-glutamine, 1 mM Na pyruvate and 100 ng/ml NGF. DRG explants were
grown for 72 h at 37˚C and 5% CO2 before they were fixed for immunofluorescence studies.
Immunofluorescence
Adult DRG neurons or embryonic DRG explants grown on coverslips for 72 h were fixed with
4% paraformaldehyde (PFA) in PBS (pH 7.4) for 15 min at room temperature. The coverslips
were washed twice with PBST (0.1% Triton x-100 in PBS) and blocked with 10% goat serum in
PBST for 30 min. Overnight incubation was performed at 4˚C with an anti-NFL primary anti-
body described before [15]. The following day, coverslips were washed three times with PBST
and incubated for 1 h with AlexaFluor-488-goat anti-rabbit IgG (H+L). Coverslips were
washed three times with PBST and mounted using Aquamount. Images were taken with a
Zeiss Axioplan 2 microscope equipped with camera AxioCam with Axiovision software
(Zeiss).
Electron microscopy
For DRG explants, adult mice were anesthetized and perfused with 4% PFA and 2% glutaralde-
hyde in 0.1 M cacodylate buffer (pH 7.4). DRGs were immersed in the same fixative for 24 h at
4˚C, washed with cacodylate buffer and post-fixed in 1% osmium tetroxide for 1 h. For dissoci-
ated DRG neurons, cells were cultured for 72 h before they were fixed with 2.5% glutaralde-
hyde in 0.1 M Sorensen’s buffer for 1 h. After three washes with Sorensen’s buffer, DRGs were
post fixed in 1% osmium for 1h. They were then dehydrated in a graded series of ethanol and
embedded in EMS-812 resin. Plastic sections (1 μm) were stained with toluidine blue and
examined for light microscopy. Ultrathin thin sections were cut on the PT-XL ultramicrotome
at 60nm thick. The sections were stained with uranyl acetate and lead citrate and examined
under a JEOL JEM-1200 EXII electron microscope. Images were captured with an ORCA-HR
digital camera (Hamamatsu) and recorded with an AMT Image Capture Engine.
Neurofilamentous inclusions in a CMT2E mouse model
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Western blotting
Cerebellum, DRG or spinal cord tissues were homogenized in ice-cold phosphate-buffered
saline (PBS) containing 1% triton X-100, sonicated and centrifuged for 30 min in 15000 rpm
at 4˚C. The supernatant was transferred to a new tube; the pellet was resuspended with PBS
containing 1% triton X-100, and processed again following the above steps. The supernatants
were combined together and used as triton X-100 soluble fraction. The pellet was resuspended
in a buffer containing 8 M urea, 2% sodium dodecyl sulfate (SDS), 50 mM Tris (pH 8.0), 50
mM Na2HPO4 and 300 mM NaCl. After resuspension and centrifugation, the supernatant was
taken out to use as triton X-100 insoluble fraction.
Protein concentrations of the soluble fraction were determined using the Coomassie Pro-
tein Assay kit (Thermo Fisher Scientific, Waltham, MA, USA). 20 μg of cerebellum, DRG and
spinal cord proteins were separated by SDS-PAGE and transferred to Immobilon-P membrane
(Millipore). The membranes were blocked with 10% fat-free milk in PBST and incubated with
primary antibodies in blocking solution overnight at 4˚C. The anti-NFL primary antibody was
the same as the one used in immunofluorescence. Anti-GAPDH antibody was purchased from
EnCor Biotechnology Inc. (Gainesville, FL, USA). After washing with PBST for three times,
the membrane was incubated with secondary antibodies for 1 h and washed with PBST for
three times. IRDye1 680RD Goat anti-Rabbit IgG (H+L) (LICOR) and 827–08364 IRDye
800CW Goat anti-Mouse IgG (H+L) (LICOR) were used as secondary antibodies. The immu-
noreactive proteins were visualized with an Odyssey infrared scanner (LICOR Biosciences).
Intensities of the blot signals were measured in arbitrary units using ImageJ. Soluble NFL pro-
tein levels were normalized to GAPDH. NFL protein levels of NeflN98S/+ mice were compared
to WT NFL protein levels, which were set to 100. Western blot of a dilution series of the sample
stained with anti-NFL was performed to confirm the linearity of the range of NFL examined in
this assay (S1 Fig). Animals were from the same litter of 4 Nefl+/+ mice and 4 NeflN98S/+ mice.
Statistical significance was set to p< 0.05 and calculated using unpaired t-test.
Discussion
Abnormal neurofilament accumulations are observed in many neurodegenerative diseases.
They have also been observed in a number of mouse models with mutations or overexpression
of neuronal intermediate filaments [4, 14, 16–22]. These neurofilament accumulations appear
to lead to neuronal dysfunction and/or loss of neurons. Transgenic mice overexpressing alpha
internexin showed axonal swelling and neurofilament misaccumulations in Purkinje cells, and
progressive loss of Purkinje neurons, as well as motor coordination deficits that preceded the
loss of the Purkinje neurons [4]. Transgenic mice overexpressing peripherin lacking NFL
expression (Per;NFL -/-) have neurofilament inclusions in both perikarya and axons of motor
neurons, whereas another mouse model overexpressing hNFH in NFL null background
(hNFH;NFL -/-) led to nonfilamentous aggregates only in the perikarya of motor neurons [16,
23]. The difference in the nature of the inclusions in these two mouse models and their differ-
ent localizations may lead to different consequences: the neurofilamentous inclusions in neur-
ites of Per;NFL -/- mice overexpressing peripherin are correlated with motor neuron death,
whereas the hNFH;NFL -/- mice developed motor dysfunction such as tremors and muscle
weakness, but did not suffer motor neuron death [16, 23]. In order to model the NEFL muta-
tion in CMT2E, we have generated a knock-in mouse with a N98S mutation in Nefl [14]. In
this study, we demonstrated that neurofilament inclusions in DRGs of NeflN98S/+ mice could
occur as early as embryos at E15. These inclusions were found in both the soma and axons of
the DRGs. We have studied in more detail the cytoskeletal organization in the DRGs and the
nature of the filaments in these inclusions and found that rather than non-filamentous
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aggregates, they consist of bundles of filaments. We hypothesize that these inclusions could
potentially be toxic and lead to the degeneration of these neurons. We believe that chemical
compounds that help remove the inclusions would be able to alleviate disease phenotypes and
bring a partial rescue.
One striking difference in cytoskeletal organization in DRG axons between Nefl+/+ and
NeflN98S/+ mice is the segregation of neurofilaments and other organelles (Fig 4E). Similar seg-
regations have been described in sural nerve of CMT2E patients [24], motor neurons of a
transgenic mouse expressing a mutant NFL [20], GAN [25], and other neuropathies induced
by β, β’-iminodiproprionitrile (IDPN) [26, 27], 2,5-hexanedione [28] and aluminum [29, 30].
However, at least two questions remain unanswered. Firstly, what is the underlying mecha-
nism of neurofilament-microtubule segregation, and second, what is the relationship between
the cytoskeletal segregation and the neurofilament accumulations. Brown and colleagues have
developed a stochastic model to explain how the segregation occurred [31]. They propose that
the neurofilament-microtubule segregation is a consequence of impaired neurofilament trans-
port, and the rate and extent of this segregation is dependent on the extent to which neurofila-
ment transport is inhibited [31]. But it is still not clear how neurofilament accumulations arise.
It has been suggested that neurofilament-microtubule segregation precedes the neurofilament
accumulation after IDPN administration [26]. Considering the decreased level of N98S NFL
proteins, it is likely that the N98S mutation destabilizes the mutant NFL protein and leads to
an impaired transport of neurofilament polymer, which causes the segregation of neurofila-
ments and microtubules, resulting in neurofilament accumulations and axonal swelling. The
disorganized cytoskeleton in axons could0 further inhibit cargo transport along axons, eventu-
ally leading to CMT2E neuropathy.
The reduced protein levels in both the soluble and insoluble fractions of NeflN98S/+ mice are
consistent with our previous finding of reduced total NFL (wild-type + mutant) protein levels
in NeflN98S/+ mice [14]. It should be noted, however, that the soluble and insoluble fractions
derived from our method do not necessarily represent an exhaustive separation of all small
subunits and polymers of neurofilaments. Nevertheless, it has been found that polymerized
neurofilament proteins forming cytoskeletons are mostly insoluble to conserve the cytoskeletal
organization [32]. Therefore, the decreased level of insoluble neurofilaments in NeflN98S/+ mice
indicates fewer polymerized neurofilaments in the cytoskeleton, which might affect cytoskele-
tal structure and function. The lower soluble/insoluble ratio in NeflN98S/+ mice suggests that
N98S mutation tilts the soluble/insoluble balance towards the insoluble, mostly in the form of
accumulations. These data combined with our previous results of decreased total protein levels
and unchanged mRNA levels in tissues of NeflN98S/+ mice suggest that faster degradation of the
mutant proteins than wild-type NFL contributes, at least partially, to the decreased NFL pro-
tein levels (wild-type plus mutant) in the NeflN98S/+ mice.
In summary, our results demonstrate that the neurofilament proteins from the NeflN98S/+
mice form inclusions in the processes and cell bodies of DRG neurons and DRG explants cul-
tured in vitro. These inclusions were already observed in DRG explant cultures from embryonic
day 15 mice. Electron microscopy studies reveal that the inclusions are predominantly disor-
dered neurofilaments packed in high density, almost exclusive of anything else. In NeflN98S/+
mice, both the triton soluble and insoluble portions of NFL proteins are reduced. Among the
total NFL pool, the soluble-insoluble balance shifts toward the triton-insoluble fraction.
Supporting information
S1 Fig. A series of diluted samples from wild-type spinal cord were analyzed by western
blotting using the rabbit anti-NFL antibody as described in the Materials and Methods
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section. Following scanning, linear regression was performed on the samples to confirm the
linearity of the range of NFL examined in this assay. Protein amounts: sample 1, 30 μg; sample
2, 27 μg; sample 3, 24 μg; sample 4, 21 μg; sample 5, 18 μg; sample 6, 15 μg; sample 7, 12 μg;
sample 8, 9 μg; sample 9, 6 μg; sample 10, 3 μg.
(TIF)
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